Skip to main content
SpringerLink
Log in
Book cover

Atlas of Osteoporosis pp 119–136Cite as

Osteoporosis Associated with Systemic Illness and Medications

  • Chapter

  • 168 Accesses

Zusammenfassung

Osteoporosis is defined as low bone mass, microarchirectural bone deterioration, and susceptibility to fracture. The primary causes of osteoporosis are estrogen deficiency after menopause and advanced age. Ten secondary causes of osteoporosis have been categorized by organ system or systemic disease. Each of these secondary causes is associated with a negative calcium balance or defects in bone formation or resorption at the bone remodeling unit. This chapter focuses on the diagnostic characteristics of these secondary causes.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rao SD, Kleerekoper M, Rogers M, et al.: Is gastrectomy a risk factor for osteoporosis? In Osteoporosis. Edited by Christiansen C, Arnaud CD, Nordin BEC, et al. Glostrop, Denmark: Aalborg Stiftsbogtrykkeri; 1984:775–777.

    Google Scholar 

  2. Trier JS: Celiac sprue. N Engl J Med 1991, 325:1709–1719.

    Article  PubMed  CAS  Google Scholar 

  3. Long RG, Meinhard E, Skinner RK, et al.: Clinical, biochemical and histological studies of osteomalacia, osteoporosis and parathyroid function in chronic liver disease. Gut 1978, 19:85–90.

    Article  PubMed  CAS  Google Scholar 

  4. Malluche HH, Langub MC, Monier-Faugere MC: Pathogenesis and histology of renal osteodystrophy. Osteoporosis Int 1997, 7:S 184—S 187.

    Article  Google Scholar 

  5. Bonnick SL: Bone Densitometry in Clinical Practice. Totowa, NJ: Humana Press; 1998:152–166.

    Google Scholar 

  6. Chiodini I, Carnevale V, Torlantano M, et al.: Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: a study in eumenorrheic patients with Cushing’s syndrome. J Clin Endocrinol Metab 1998, 83:1863–1867.

    Article  PubMed  CAS  Google Scholar 

  7. Riggs BL: Osteoporosis. In Textbook of Endocrinology. Edited by DeGroot LJ. Orlando, FL: Grune & Stratton; 1987.

    Google Scholar 

  8. Chines A, Pacifici R, Avioli LA, et al.: Systemic mastocytosis and osteoporosis. Osteoporosis Int 1993, S1:S 147-S 149.

    Article  Google Scholar 

  9. Gebhardt MC, Mankin HJ:The diagnosis and management of bone tumors. In Metabolic Bone Disease and Clinically Related Disorders. Edited by Avioli LV, Krane SM. Philadelphia: WB Saunders; 1990:777–780.

    Google Scholar 

  10. Silverberg SJ, ShaneE, de la Cruz L, et al.: Skeletal disease in primary hyperparathyroidism. J Bone Miner Metab 1989, 4:283–291.

    CAS  Google Scholar 

  11. Seeman E, Wahner HW, Offord KP, et al.: Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 1982, 69:1302–1309.

    Article  PubMed  CAS  Google Scholar 

  12. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC: Inhibition of osteohistogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998, 102:274–282.

    Article  PubMed  CAS  Google Scholar 

  13. Pitkin RM: Calcium metabolism in pregnancy. A review. Am J Obstet Gynecol 1975, 12:724–737.

    Google Scholar 

  14. Heaney RP: Nutritional factors in osteoporosis. Annu Rev Nutr 1993, 13:287–316.

    Article  PubMed  CAS  Google Scholar 

  15. Parfitt AM: Osteomalacia and related disorders. In Metabolic Bone Disease and Clinically Related Disorders. Edited by Avioli LV, Krane SM. Philadelphia: WB Saunders; 1990:329–396.

    Google Scholar 

  16. Hirano T, Tanizawa T, Endo N, et al.: Oncogenic osteomalacia: pre- and postoperative histomorphometric studies. J Bone Miner Metab 1997, 15:227–231.

    Article  Google Scholar 

  17. Coburn JW, Norris KC, Nebeker HG: Osteomalacia and bone disease arising from aluminum. Semin Nephrol 1986, 6:68–89.

    PubMed  CAS  Google Scholar 

  18. Glorieux FH, Bishop NJ, Plotkin H, et al.: Cyclic administration of Pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998, 339:947–952.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Paul D. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Endocrinology, General Clinical Research Center, Oregon Health and Science University, Portland, Oregon, USA

    Eric S. Orwoll MD (Professor of Medicine, Program Director) (Professor of Medicine, Program Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Miller, P.D. (2003). Osteoporosis Associated with Systemic Illness and Medications. In: Orwoll, E.S. (eds) Atlas of Osteoporosis. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4561-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4561-0_11

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4757-4563-4

  • Online ISBN: 978-1-4757-4561-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation